Gsk (GSK) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $32.4 million.
- Gsk's Other Operating Expenses rose 10743.85% to $32.4 million in Q3 2025 from the same period last year, while for Dec 2025 it was $178.6 million, marking a year-over-year increase of 10513.75%. This contributed to the annual value of -$2.0 billion for FY2024, which is 33316.23% down from last year.
- Latest data reveals that Gsk reported Other Operating Expenses of $32.4 million as of Q3 2025, which was up 10743.85% from $160.1 million recorded in Q2 2025.
- Gsk's 5-year Other Operating Expenses high stood at $890.3 million for Q4 2022, and its period low was -$2.0 billion during Q4 2024.
- Moreover, its 5-year median value for Other Operating Expenses was -$344.6 million (2021), whereas its average is -$245.9 million.
- In the last 5 years, Gsk's Other Operating Expenses plummeted by 120194.06% in 2021 and then soared by 27995.08% in 2022.
- Over the past 5 years, Gsk's Other Operating Expenses (Quarter) stood at -$494.7 million in 2021, then soared by 279.95% to $890.3 million in 2022, then tumbled by 179.61% to -$708.7 million in 2023, then tumbled by 177.09% to -$2.0 billion in 2024, then skyrocketed by 101.65% to $32.4 million in 2025.
- Its Other Operating Expenses was $32.4 million in Q3 2025, compared to $160.1 million in Q2 2025 and -$13.9 million in Q1 2025.